Arcutis Announces Publication of ZORYVE(R) (roflumilast) Cream 0.15% Pivotal Results from Phase 3 INTEGUMENT-1 and -2 Trials in Mild to Moderate Atopic Dermatitis in Journal of American Medical Association Dermatology

ZORYVE(R) (roflumilast) cream 0.15% improved atopic dermatitis (AD) across multiple efficacy endpoints while demonstrating favorable safety and tolerability Across both studies, approximately 31% of children and adults treated with ZORYVE cream achieved the primary efficacy endpoint of Investigator Global Assessment (IGA) Success at Week 4 compared to 14% for vehicle, with significant improvement as early […]

TRM Labs Secures FedRAMP(R) Moderate Authorization, Expanding Federal Offerings

SAN FRANCISCO, Sept. 19, 2024 (GLOBE NEWSWIRE) — TRM Labs, a leader in blockchain intelligence, today announced that it is the first blockchain intelligence company to achieve FedRAMP Moderate authorization. TRM Labs and Palantir have partnered through Palantir’s FedStart Program to accelerate TRM Labs’ ability to support a broader range of federal customers by meeting

TSX Approves ECN Capital’s Normal Course Issuer Bids for Common Shares and Series C Preferred Shares

TORONTO, Sept. 19, 2024 (GLOBE NEWSWIRE) — ECN Capital Corp. (TSX: ECN, ECN.PR.C) (“ECN Capital” or the “Company”) today announced that the Toronto Stock Exchange (the “TSX”) has approved the Company’s notice of intention to commence a normal course issuer bid (the “Common Share Bid”) for common shares of the Company (the “Common Shares”) and

New Solution from Microchip Makes it Easier to Build Sophisticated Graphical User Interfaces for MPLAB(R) Harmony v3 and Linux(R) Environments

CHANDLER, Ariz., Sept. 19, 2024 (GLOBE NEWSWIRE) — Designers are incorporating Graphical User Interfaces, or GUIs, into more electronic devices to enhance the user experience by providing intuitive and visually appealing interactions with today’s modern applications. To support embedded developers with their designs, Microchip Technology (Nasdaq: MCHP) today announces Microchip Graphics Suite (MGS), an easy-to-learn,

Pinpoint Predictive Announces Membership with NAMIC

San Mateo, California, Sept. 19, 2024 (GLOBE NEWSWIRE) — Pinpoint Predictive, Inc, the leading Loss Prediction and Risk Score platform for the P&C insurance industry, is delighted to announce it has become a member of The National Association of Mutual Insurance Companies (NAMIC), the organization providing advocacy, education, and association services to its growing network

Experience Tranquility and Mindfulness with Stingray Naturescape and ZenLIFE by Stingray on Amazon Fire TV Channels

MONTREAL, Sept. 19, 2024 (GLOBE NEWSWIRE) — Stingray (TSX: RAY.A; RAY.B), an industry leader in music and video content distribution, business services, and advertising solutions, proudly announces the launch of two new free ad-supported TV channels, Stingray Naturescape and ZenLIFE, on Amazon Fire TV Channels. These channels are designed to bring tranquility and wellness into

Fox Factory Debuts First Team in Rebelle Rally 2024

DULUTH, Ga., Sept. 19, 2024 (GLOBE NEWSWIRE) — Fox Factory Holding Corp. (Nasdaq: FOXF) announced it is fielding its first team to compete in the Rebelle Rally, the longest competitive off-road navigation rally in the United States and the first women’s endurance off-road rally in America. Kristen Matlock, professional driver and FOX-supported athlete, along with

Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024

Oak Ridge, TN, Sept. 19, 2024 (GLOBE NEWSWIRE) — Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces its participation in the Annual Scientific Meeting of the Heart Failure Society of America (HFSA), taking place September 27-30 at the Georgia World Congress Center and Signia by Hilton Atlanta. The event

Evaxion launches improved AI-Immunology(TM) platform for vaccine antigen prediction

The new version 5.0 of the AI model EDEN(TM) features a novel toxin antigen predictor, is trained on an expanded dataset and includes an advanced protein prediction feature The launch will expectedly improve Evaxion’s ability to fast and effectively discover AI-derived novel vaccines and is expected to further solidify the strong interest seen in AI-Immunology(TM)

Helsinn Group appoints Riccardo Carbucicchio to the Board of Directors

Helsinn Group appoints Riccardo Carbucicchio to the Board of Directors Lugano, Switzerland – September 19, 2024 – Helsinn Group (“Helsinn”), a global pharmaceutical company with a track record of over forty-five years of commercial execution and a strong focus in supportive care, oncology and dermato-oncology, is pleased to announce the appointment of Riccardo Carbucicchio as

Scroll to Top